Allan Reine is Chief Financial Officer of Foghorn Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Prime Medicine, Inc.
21 May 24
4
Prime Medicine, Inc.
19 Jan 24
3
Prime Medicine, Inc.
19 Jan 24
4
Foghorn Therapeutics Inc.
17 Jan 24
4
Foghorn Therapeutics Inc.
30 Jan 23
4
Foghorn Therapeutics Inc.
28 Jan 22
4
Foghorn Therapeutics Inc.
11 Aug 21
4
Foghorn Therapeutics Inc.
1 Feb 21
3
Foghorn Therapeutics Inc.
22 Oct 20
4
PIERIS PHARMACEUTICALS, INC.
28 Feb 19
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 May 24 | PRME Prime Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 6.8 | 100,000 | 680.00 k | 100,000 |
17 Jan 24 | PRME Prime Medicine | Stock Option Common Stock | Grant | Acquire A | No | No | 6.8 | 600,000 | 4.08 mm | 600,000 |